Glaucoma, often called the silent thief of sight, can cause permanent damage without early symptoms. Early diagnosis and timely treatment remain essential to preserving sight.
Today’s care options help doctors intervene earlier and more effectively. Advanced laser therapies, minimally invasive glaucoma surgery, and long-duration treatments allow teams to lower eye pressure and support quality of life.
iDose TR from Glaukos
Barnet Dulaney Perkins practices offer the FDA-approved iDose TR (travoprost intracameral implant) from Glaukos for eligible adults with open-angle glaucoma or ocular hypertension. The tiny implant is placed during a brief in-office procedure. It delivers a steady amount of medication over time to help lower intraocular pressure. Treatment plans are individualized, and not every patient will be a candidate.
Who May Benefit
-
Adults diagnosed with open-angle glaucoma or ocular hypertension, as determined by their eye doctor.
-
Patients who have difficulty staying on daily eye drops.
-
Patients who may benefit from steady, long-duration pressure-lowering as part of a broader care plan.
What to Expect
-
A comprehensive evaluation, including pressure checks and imaging.
-
A discussion of medical drops, laser options, and surgical options.
-
If appropriate, an in-office iDose TR procedure, followed by routine follow-up visits and ongoing monitoring.
Safety and Eligibility
All glaucoma care is personalized. Every procedure carries risks; your doctor will review potential risks and benefits and will decide with you if iDose TR fits your needs.
Barnet Dulaney Perkins Eye Center provides comprehensive glaucoma management, from screening and monitoring to advanced procedures when needed. Patients can schedule a consultation to learn which options may be right for them.